Cancer

A new study concluded that the residual cancer cells that survived the initial anticancer treatment could exploit our immune system leading to cancer recurrence. The study, jointly-funded by European Research Council, the Richard M Schulze Family Foundation, the Mayo Foundation, Cancer Research UK, and the US National Institutes of Health was recently published in the journal of Cancer Immunology Research. The study was carried out in mice where researchers investigated…

Infection is one of the most common life-threatening complications of cancer and cancer treatment. Immunosuppression resulting from cancer and chemotherapy places patients at a higher risk of contracting infections, as well as increasing the severity of infection. In the general population, vaccination is a simple yet important process used to prevent many infections. However, studies have indicated that immunosuppression reduces the effectiveness of the vaccines. Studies have reported the rates…